semaglutide news Kids approved for weight loss drugs! NCSHP will tighten coverage of

GLP-1 receptor agonists, such as semaglutide (sold under the brand name Ozempic or Wegovy) and tirzepatide (brand name Mounjaro or Zepbound), are medications originally developed for diabetes and now approved for chronic weight management at specific doses

"Policy options to cover anti-obesity drugs." georgetown.edu Medicare.gov

The most common gaps we see: Low appetite low protein intake , which puts hard-earned lean muscle at risk during weight loss Smaller food volume vitamin and mineral gaps that build up over months of treatment Slowed digestion occasional nausea, bloating, and constipation , especially in the first weeks and after dose increases Less eating and drinking overall low energy that makes staying active harder Biocare was scientifically designed to do that whole job in one shake

Disclaimer: The information provided in this article is for educational purposes only and should not be considered medical advice

These beneficial microorganisms don't just passively exist in your gutthey actively participate in your metabolic health through several remarkable mechanisms (4,5,6,8)